(Q28332949)
Statements
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer (English)
0 references
15 September 1991
0 references
78
0 references
6
0 references
1420-7
0 references